Recording: AI in Healthcare: Real World Data Generation and the Regulatory Perspective
DCI Network presents our latest webinar "AI in Healthcare: Real World Data Generation and the Regulatory Perspective"
The pervasive integration of AI into every facet of our lives is an indisputable trend, and its most profound ramifications are notably pronounced within the healthcare domain. This influence came to the forefront at the HIMSS meeting held in April, where practically every prominent company in attendance at the trade show was showcasing their advancements driven by AI technology. This notable upsurge in the adoption of AI holds a range of far-reaching implications for the healthcare industry.
In the wake of this rapid expansion, it becomes imperative to raise and address pertinent questions regarding the data utilized for training AI systems. Considerations extend to the policy and regulatory dimensions of these decisions, along with the strategies regulatory bodies can employ to uphold trust and safety in this new era.
These inquiries, among others, will be the focal point of discussion during the final installment of our four-part webinar series, presented by the Division of Clinical Informatics. We are privileged to have Mark Shapiro, the COO of xCures, and Rob Stolper from IQVIA as speakers. They will delve into the regulatory implications concerning real-world data essential for training AI systems, as well as the methods to ensure the provision of accurate and reliable training data for these AI systems.
We cordially invite you to join us on Wednesday, September 13, for this engaging discourse. Participation in the webinar is free and open to the public, but we kindly request that you complete the registration process to secure your spot.
This is the ultimate webinar in a 4-part DCI Network Webinar Series exploring AI in Healthcare.
Real World Data Expert, National Cancer Institute (NCI)
Adjunct Associate Professor, Department of Epidemiology, University of North Carolina at Chapel Hill
Dr. Meyer is currently working for the National Cancer Institute (NCI) as an expert on RWD strategy and data quality. She also maintains an Adjunct Associate Professor role at the University of North Carolina at Chapel Hill in the Department of Epidemiology. She has over 20 years’ experience combining epidemiology and clinical informatics to tackle important problems in public health, health policy, cancer outcomes and personalized healthcare. Dr. Meyer has engaged in many interdisciplinary collaborations to measure disparities in care; untangle the many influences on patient care; and design interventions to improve outcomes for patients. She has spent time in both academia and industry as a Director of Real-World Evidence at Quintiles, Sr. Principal Data Scientist at Roche Personalized Health Care and Head of Epidemiology and real-world data (RWD) in a Silicon Valley start-up. Dr. Meyer has a passion for innovating on large, real-world, and observational data for health research. Her work focuses on developing novel methods for extracting, organizing, managing, linking and using RWD to make the data more systematic and accessible for all stakeholders.
Chief Operating Officer, xCures Inc.
Mark Shapiro is the COO of xCures and principal investigator for XCELSIOR a patient-powered real-world data and outcomes registry in cancer. Prior to joining xCures, Mr. Shapiro was SVP, Operations at a global oncology CRO, where he was responsible for a team of about 500 drug development professionals in 30 countries, and a portfolio of more than 100 active clinical trials.
He was previously a management consultant in the Clinical Development and Medical Affairs consulting practice at Syneos Health Consulting. He also managed a pediatric clinical trials network coordinating center at Duke University focused on clinical, pharmacogenomic, and psychometric research. He has published many peer-reviewed articles and patent applications related to clinical research and the use of AI/ML in clinical research and medicine.
Mr. Shapiro is a graduate of the Fuqua School of Business at Duke University and holds a Master’s degree in Pharmacology from the Boston University, School of Medicine.
Managing Principal, Head of Enterprise Transformation Strategy, IQVIA
Robert Stolper is Managing Principal and Head of Enterprise Transformation Strategy at IQVIA. He brings almost 25 years of experience partnering with biopharmaceutical companies to build innovative clinical development and commercialization strategies at the enterprise, portfolio, and product level. He has a particular focus and interest in facilitation of strategic decision making using advanced analytics, including AI, and has experience leveraging a range of real-world datasets to improve diagnosis and treatment of patients across diseases. Prior to IQVIA, Rob has held leadership positions in AIML healthcare start-ups and global strategy consulting firms. He is a graduate of Harvard University with a degree in Biochemical Sciences.
Steven E. Labkoff, MD, FACP, FACMI, FAMIA
Global Head, Clinical and Healthcare Informatics, Quantori
Collaborating Scientist, Division of Clinical Informatics, Beth Israel Deaconess Medical Center, Harvard Medical School
27 September 2023
27 September 2023
All Rights Reserved